These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 'Rescue' therapies for the management of Helicobacter pylori infection. Di Mario F; Cavallaro LG; Scarpignato C Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270 [TBL] [Abstract][Full Text] [Related]
4. Treatment for H. pylori infection: new challenges with antimicrobial resistance. Vakil N; Vaira D J Clin Gastroenterol; 2013; 47(5):383-8. PubMed ID: 23388847 [TBL] [Abstract][Full Text] [Related]
11. Toward population specific and personalized treatment of Helicobacter pylori infection. Liou JM; Chen PY; Kuo YT; Wu MS; J Biomed Sci; 2018 Oct; 25(1):70. PubMed ID: 30285834 [TBL] [Abstract][Full Text] [Related]
12. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844 [TBL] [Abstract][Full Text] [Related]
13. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Gisbert JP; Gisbert JL; Marcos S; Pajares JM Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810 [TBL] [Abstract][Full Text] [Related]
14. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Romano M; Cuomo A; Gravina AG; Miranda A; Iovene MR; Tiso A; Sica M; Rocco A; Salerno R; Marmo R; Federico A; Nardone G Gut; 2010 Nov; 59(11):1465-70. PubMed ID: 20947881 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Helicobacter pylori. Egan BJ; Katicic M; O'Connor HJ; O'Morain CA Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458 [TBL] [Abstract][Full Text] [Related]
17. Current and future insights in H. pylori eradication regimens: the need of tailoring therapy. Papastergiou V; Georgopoulos SD; Karatapanis S Curr Pharm Des; 2014; 20(28):4521-32. PubMed ID: 24180408 [TBL] [Abstract][Full Text] [Related]
18. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. Polat Z; Kadayifci A; Kantarcioglu M; Ozcan A; Emer O; Uygun A Eur J Intern Med; 2012 Mar; 23(2):165-8. PubMed ID: 22284248 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Fischbach L; Evans EL Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]